Ballentine Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.42M | Sell |
5,428
-409
| -7% | -$182K | 0.04% | 168 |
|
|
2025
Q1 | $2.83M | Buy |
5,837
+247
| +4% | +$120K | 0.05% | 135 |
|
|
2024
Q4 | $2.25M | Buy |
5,590
+119
| +2% | +$47.9K | 0.04% | 157 |
|
|
2024
Q3 | $2.54M | Buy |
5,471
+123
| +2% | +$57.2K | 0.04% | 143 |
|
|
2024
Q2 | $2.51M | Buy |
5,348
+470
| +10% | +$220K | 0.05% | 131 |
|
|
2024
Q1 | $2.04M | Buy |
4,878
+309
| +7% | +$129K | 0.04% | 151 |
|
|
2023
Q4 | $1.86M | Buy |
4,569
+201
| +5% | +$81.8K | 0.04% | 149 |
|
|
2023
Q3 | $1.52M | Buy |
4,368
+892
| +26% | +$310K | 0.04% | 149 |
|
|
2023
Q2 | $1.22M | Buy |
3,476
+131
| +4% | +$46.1K | 0.03% | 179 |
|
|
2023
Q1 | $1.05M | Buy |
3,345
+893
| +36% | +$281K | 0.03% | 189 |
|
|
2022
Q4 | $708K | Buy |
2,452
+436
| +22% | +$126K | 0.02% | 226 |
|
|
2022
Q3 | $584K | Buy |
2,016
+504
| +33% | +$146K | 0.02% | 224 |
|
|
2022
Q2 | $426K | Buy |
1,512
+131
| +9% | +$36.9K | 0.02% | 261 |
|
|
2022
Q1 | $360K | Sell |
1,381
-279
| -17% | -$72.7K | 0.01% | 314 |
|
|
2021
Q4 | $364K | Buy |
+1,660
| New | +$364K | 0.01% | 333 |
|
|
2021
Q3 | – | Sell |
-1,023
| Closed | -$206K | – | 438 |
|
|
2021
Q2 | $206K | Sell |
1,023
-84
| -8% | -$16.9K | 0.01% | 398 |
|
|
2021
Q1 | $238K | Sell |
1,107
-128
| -10% | -$27.5K | 0.01% | 343 |
|
|
2020
Q4 | $291K | Sell |
1,235
-227
| -16% | -$53.5K | 0.01% | 291 |
|
|
2020
Q3 | $398K | Buy |
1,462
+16
| +1% | +$4.36K | 0.02% | 232 |
|
|
2020
Q2 | $420K | Sell |
1,446
-49
| -3% | -$14.2K | 0.02% | 225 |
|
|
2020
Q1 | $356K | Buy |
1,495
+84
| +6% | +$20K | 0.02% | 226 |
|
|
2019
Q4 | $309K | Buy |
1,411
+58
| +4% | +$12.7K | 0.01% | 296 |
|
|
2019
Q3 | $230K | Sell |
1,353
-8
| -0.6% | -$1.36K | 0.01% | 347 |
|
|
2019
Q2 | $250K | Buy |
+1,361
| New | +$250K | 0.01% | 320 |
|
|
2017
Q4 | – | Sell |
-1,825
| Closed | -$277K | – | 413 |
|
|
2017
Q3 | $277K | Sell |
1,825
-3
| -0.2% | -$455 | 0.02% | 284 |
|
|
2017
Q2 | $295K | Buy |
+1,828
| New | +$295K | 0.02% | 278 |
|